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Abstract
Background: Skeletons are formed in a wide variety of shapes, sizes, and compositions of organic and mineral components.
Many invertebrate skeletons are constructed from carbonate or silicate minerals, whereas vertebrate skeletons are instead
composed of a calcium phosphate mineral known as apatite. No one yet knows why the dynamic vertebrate skeleton,
which is continually rebuilt, repaired, and resorbed during growth and normal remodeling, is composed of apatite. Nor is
the control of bone and calcifying cartilage mineralization well understood, though it is thought to be associated with
phosphate-cleaving proteins. Researchers have assumed that skeletal mineralization is also associated with non-crystalline,
calcium- and phosphate-containing electron-dense granules that have been detected in vertebrate skeletal tissue prepared
under non-aqueous conditions. Again, however, the role of these granules remains poorly understood. Here, we review
bone and growth plate mineralization before showing that polymers of phosphate ions (polyphosphates: (PO3
2)n) are co-
located with mineralizing cartilage and resorbing bone. We propose that the electron-dense granules contain
polyphosphates, and explain how these polyphosphates may play an important role in apatite biomineralization.
Principal Findings/Methodology: The enzymatic formation (condensation) and destruction (hydrolytic degradation) of
polyphosphates offers a simple mechanism for enzymatic control of phosphate accumulation and the relative saturation of
apatite. Under circumstances in which apatite mineral formation is undesirable, such as within cartilage tissue or during
bone resorption, the production of polyphosphates reduces the free orthophosphate (PO4
32) concentration while
permitting the accumulation of a high total PO4
32 concentration. Sequestering calcium into amorphous calcium
polyphosphate complexes can reduce the concentration of free calcium. The resulting reduction of both free PO4
32 and
free calcium lowers the relative apatite saturation, preventing formation of apatite crystals. Identified in situ within resorbing
bone and mineralizing cartilage by the fluorescent reporter DAPI (49,6-diamidino-2-phenylindole), polyphosphate formation
prevents apatite crystal precipitation while accumulating high local concentrations of total calcium and phosphate. When
mineralization is required, tissue non-specific alkaline phosphatase, an enzyme associated with skeletal and cartilage
mineralization, cleaves orthophosphates from polyphosphates. The hydrolytic degradation of polyphosphates in the
calcium-polyphosphate complex increases orthophosphate and calcium concentrations and thereby favors apatite mineral
formation. The correlation of alkaline phosphatase with this process may be explained by the destruction of polyphosphates
in calcifying cartilage and areas of bone formation.
Conclusions/Significance: We hypothesize that polyphosphate formation and hydrolytic degradation constitute a simple
mechanism for phosphate accumulation and enzymatic control of biological apatite saturation. This enzymatic control of
calcified tissue mineralization may have permitted the development of a phosphate-based, mineralized endoskeleton that
can be continually remodeled.
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Introduction
Biomineralization processes provide fascinating, complex, and
solid structures for many life forms [1]. Numerous invertebrates
manipulate carbonate chemistry to control the crystallization of
different calcium carbonate mineral polymorphs such as aragonite
or calcite within organic matrices. These remarkable structures
boast excellent material properties that provide advantages in both
protection and predation. Other marine organisms, such as
sponges and diatoms, biomineralize intricate silicate structures
by controlling the nucleation and condensation of silicate ions.
Mineralized vertebrate skeletons instead contain crystals of
apatite, a calcium- and phosphate-based mineral. In this section,
we will first outline apatite, skeletal remodeling, and mineraliza-
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electron-dense granules that contain calcium and phosphate and
have been identified in skeletal tissue and mitochondria prepared
with non-aqueous methods. Next, we will summarize tissue-
nonspecific alkaline phosphatase as it relates to apatite mineral-
ization. Thereafter, we will show how all these topics can be tied
together by explaining the relationship between polyphosphates
and biological apatites.
We propose that the vertebrate skeleton contains apatite
mineral because apatite saturation can be enzymatically controlled
by the formation and destruction of polyphosphate (polyP) ions.
Calcium-polyP complexes serve as bioavailable stores of high
concentrations of calcium and orthophosphate ((PO4)
32:Pi) when
apatite formation is not desired. When its mineralization is
required, however, tissue-nonspecific alkaline phosphatase pro-
duces orthophosphate from polyP, concurrently releasing any
calcium previously sequestered by the polyphosphate, and
increasing apatite saturation.
The abbreviations in this manuscript include polyphosphate
(polyP), orthophosphate (Pi), hydroxyapatite (HAP), relative
saturation with respect to HAP (sHAP), alkaline phosphatase
(ALP), and tissue-nonspecific alkaline phosphatase (TNAP).
Vertebrate bone - why apatite?
The vertebrate skeleton is predominately composed of bone, a
mineralized tissue that is a composite of type-I collagen, non-
collagenous proteins, and apatite (Ca10(PO4)6X2, X=mostly F or
OH) crystals [1]. No explanations yet exist [2] for why apatite is
the mineral component of choice for the vertebrate skeleton [3,4].
In vertebrates, apatite crystals contain mostly calcium, phosphate,
and carbonate [5] ions, and are on the order of tens of A ˚ngstroms
in size [6]. Biological apatites are generally not perfectly ordered
on an atomic scale—they are considered poorly crystalline [7] and
highly substituted with cations such as magnesium, strontium, and
sodium; with anions such as fluoride; and with the polyatomic
anions carbonate and hydroxyl [8]. Apatite is the only calcium-
phosphate mineral phase that is stable at both a neutral and basic
pH [9]. The high functionality and metabolic activity of the
vertebrate skeleton suggest that apatite offers an advantage to the
vertebrate organism that other minerals do not.
Vertebrate skeletal metabolism and mineralization
Unlike invertebrate skeletons or protective shells, the vertebrate
skeleton must satisfy a wide range of demands, including structural
integrity, metabolic activity, growth, and continual repair of wear
and damage caused by locomotion and/or trauma. These
demands require that vertebrates continually resorb and rebuild
their mineralized skeleton. ‘‘Remodeling’’ is the term used to
describe this controlled destruction (resorption) and rebuilding.
Newly formed bone (called osteoid) is a largely unmineralized
collagenous matrix.
Mineralization of new, unmineralized skeletal tissue generally
falls into two classes: intramembranous and endochondral
ossification. Intramembranous ossification refers to the minerali-
zation of newly formed osteoid. Endochondral ossification occurs
in the expanding growth plate, a dynamic region of the young
skeleton located beneath the soft articular cartilage that caps the
ends of the growing long bones, and above the mineralized bone
itself. These bones grow along their vertical axis through the
progressive expansion of the epiphyseal (growth) plate. Within the
active growth plates, the bone elongates as new cartilage forms on
its ends. Older cartilage beneath that new-formed cartilage
mineralizes with apatite; it is then resorbed by bone-resorbing
cells (osteoclasts) that remove both calcified cartilage and
mineralized bone. Finally, cells called osteoblasts build new bone
to replace the resorbed calcified cartilage. This is one process that
increases the size of the skeleton [10].
Because mineralized tissue is subject to damage and is
metabolically active, mineralized bone is continually remodeled
by the action of the basic multicellular unit (BMU) [11]. The BMU
is composed of two cell types: bone resorbing osteoclasts and bone
building osteoblasts. In the accepted model of bone resorption, the
osteoclasts form a sealed resorption zone at the bone surface. The
acidic environment of this sealed-off zone generates a ‘‘resorption
pit’’ as it dissolves the bone mineral, subsequently releasing
enzymes into the pit to digest the exposed collagen. Once the
sealed, ruffled border of the resorption zone is broken, the
osteoclasts can migrate to form a new resorption zone elsewhere.
Curiously, the dissolved apatite mineral does not spontaneously re-
precipitate within the resorption pit, even when the newly
reopened zone returns to a neutral pH.
The void left by the excavating osteoclasts is filled with new
bone formed by the osteoblasts. These bone-building cells lay
down osteoid that in humans mineralizes 15 to 20 days later, a
poorly understood period known as the mineralization lag time
[12]. One unresolved question concerns the whereabouts of the
apatite mineral components after they dissolve during bone
resorption and before they reappear as new mineral within new
bone. Bone tissue formation is understood to be a sequential
process, but a clear understanding of the mechanism(s) in the early
stages of mineralization has been elusive [13,14].
This study revisits previously unexplained observations of early
mineralization in fresh specimens of mineralizing bone and
calcifying cartilage that have been processed with non-aqueous
methods, as well as a previously published hypothesis linking bone
mineralization to polyphosphate (polyP) ions. PolyPs and pyro-
phosphates (P2O7)
42 are known to be apatite crystal growth
inhibitors [15–17]. Nevertheless, we propose that the production
of polyPs, which form strong complexes with divalent cations such
as calcium [18], can lead to a high local accumulation of total
phosphate and calcium that exceeds the supersaturation limit of
apatite without triggering the spontaneous precipitation of any
apatite crystals. The controlled destruction of polyPs and
subsequent production of Pi and free calcium can likewise exceed
the local apatite supersaturation limit, only in this case it favors
apatite mineral formation.
Polyphosphates
Polyphosphates are synthesized by the condensation of
phosphate species through dehydration processes such as heating
[19,20] or enzymatic condensation [21]. In this context,
condensation means the merging of two orthophosphates, one
orthophosphate and one polyP, or two polyP molecules to yield
one longer polyP molecule and water. The condensed phosphate
ions are linked together as polymers through phosphoanhydride
(P-O-P) bonds. Unlike silicate ions, which condense in three-
dimensional networks, linear polyP ions are the common species in
aqueous environments [22].
Thermodynamics favor the hydrolytic degradation of P-O-P
bonds exposed to water [20], resulting in the formation of two
shorter polyP chains, or, more commonly, the formation of an
orthophosphate ion and a shorter polyP chain. Interestingly, the
kinetics of polyP hydrolytic degradation are slow at neutral pH
and ambient temperatures [19]. This property suggests that the
phosphoanhydride bond is an excellent candidate for enzymatic
control. Researchers continue to identify enzymes responsible for
the production (polyphosphate kinases) and degradation (polypho-
sphatases) of polyP through cleavage of orthophosphate (Pi) ions
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the middle of polyP chains (endopolyphosphatases) [23]. PolyP
complexes have been identified in eukaryotic membranes [24],
mammalian cells and tissues [25], human platelets [26],
prokaryotes, fungi, plants, and animals [23]. Many of the
biochemical roles that polyPs play also have been studied
[23,27]. These roles range from energy production and cation
sequestration to blood coagulation and fibrinolysis [28]. The
participation of polyPs in bone mineralization has been previously
proposed [29] but remains unexplained. PolyPs also have been
identified in yeast mitochondria [30], where they serve as a
bioavailable phosphate reserve—a role predicted decades ago
[31]. Additionally, polyPs have been identified within dense
‘‘volutin’’ granules found in many microorganisms [32]; ‘‘electron-
dense’’ granules that contain polyP have been recently linked to
apatite biomineralization processes [33,34].
Electron-dense, amorphous (non crystalline) calcium
phosphate granules
Electron-dense granules have been identified in a wide range of
organisms [35] and were summarized in a recent review by Ryall
[36]. Numerous types of calcium-containing, electron-dense
granules exist in biology, some of which contain calcium,
phosphate, magnesium, and carbonate. The list of proposed
functions for these granules includes waste disposal, osmoregula-
tion, excretion of excess ions, calcium/phosphate/carbonate
storage and mobilization, and skeletal function [36]. In the
1960s, scientists studied amorphous and electron-dense granules
containing calcium and phosphate and appearing within mito-
chondria [37,38]. The participation of mitochondria in apatite
biomineralization has been proposed previously, but never
explained [38–40].
Mitochondria, polyphosphates and biomineralization
PolyPs are known to be employed by mitochondria as a means
for storing relatively high concentrations of bioavailable ortho-
phosphate without precipitating apatite crystals [30]. Electron-
dense granules that ranged from 500–1000 A ˚ within rat liver
mitochondria were determined to contain calcium and phosphate
at concentrations of ,0.5 M, exceeding the solubility product of
calcium phosphate and calcium pyrophosphate minerals [41,42] at
neutral pH [37]. In 1964, Lehninger’s group used X-rays to show
that these calcium- and phosphate-containing granules were non-
crystalline (amorphous) [38].
Localized and unstable granules containing high concentrations
of calcium and phosphate were also identified in the mitochondria
of proliferating and hypertrophic mineralizing chondrocytes
[43,44]. Their location suggests that these granules are associated
with the calcification process. This observation required frozen,
fresh, or non-aqueous sample preparation, however, because
unknown chemical reactions induced by aqueous methods
interfered with the granule detection [43].
Skeletal tissue and electron-dense granules are affected
by sample preparation
The study of tissue mineralization has been hindered by sample
preparation techniques because skeletal minerals are labile and
often affected by aqueous processing methods [45–47]. Previous
electron microscope examination of unstained growing bone
processed with non-aqueous methods has revealed electron-dense
‘‘granules’’ within the mineralizing osteoid matrix, including
within the mitochondria of osteoblasts, osteocytes and osteoclasts
[47–49]. Similar granules with a high total calcium and phosphate
content, an unexpected amorphous structure, and a low calcium to
phosphorus ratio were previously detected by electron microscopy
in rat growth plate cartilage [43]. The study authors, however, did
not explain either the amorphous nature of these granules or their
instability when exposed to aqueous processing methods [43].
Mitochondrial electron-dense granules that proved sensitive to
calcium fixation were identified in chondrocytes; adding calcium
to the osmium-fixation processing method enhanced the granules’
stability [44].
In the late 1960s, researchers reported a transient histological
staining of the growth plate that was dependent on the sample
preparation method. Studies demonstrated transient staining of
fresh rat epiphyseal cartilage in the matrices of resting and
hypertrophic zones, as well as in proliferating and hypertrophic
chondrocytes, while no such staining was observed with cartilage
that had been frozen and thawed or processed with standard
histological methods [50,51]. It was proposed that a change in the
unstable granules might factor into the calcification of cartilage.
Electron microscopy of the epiphyseal growth plate suggested that
the mitochondrial granules composed of unstable, amorphous
calcium salts were likely candidates for the nucleation sites
necessary for skeletal mineralization [44].
Skeletal mineralization and alkaline phosphatase
One of the putative organic components of the skeletal
mineralization process was first identified in 1923. Robison [52]
suggested that a phosphatase enzyme located within calcifying
cartilage could yield free phosphate ions, implying that phospha-
tase is ‘‘omnipresent and essential in calcifying areas’’ [53]. Tissue-
nonspecific alkaline phosphatase (TNAP) is an isoenzyme of
alkaline phosphatase [54], which is expressed in liver, kidney, and
skeletal tissues; specific examples include hypertrophic chondro-
cytes [55] and osteoblast cells [56]. TNAP is also presumed to be
involved in skeletal mineralization [57], but its substrate(s) is not
well defined. Bone and cartilage mineral formation is associated
with the presence of TNAP, which was proposed to control the
concentration of orthophosphate available for apatite mineral
formation [58]. An enzymatic characterization of alkaline
phosphatase from bovine epiphyseal cartilage noted the hydrolytic
degradation of a variety of phosphate esters, as well as of ATP and
pyrophosphate [59].
Summary
In 1961, Fleisch and Neuman proposed that the role of
phosphatase in bone is to destroy a mineralization inhibitor,
‘‘perhaps a polyphosphate’’ [60]. Herein, we present experimental
data that support their hypothesis, and expand their proposal to
include the hypothesis that polyP formation provides a mechanism
for accumulating phosphate, thus controlling apatite supersatura-
tion at locations such as sites of cartilage calcification and bone
resorption. We also demonstrate that polyPs are located in areas of
resorbing bone and calcifying cartilage, and that TNAP cleaves
orthophosphate from polyphosphate. Furthermore, we show that
exogenously applied, intestinal alkaline phosphatase (IAP), an
enzyme known to cleave orthophosphates from polyphosphates
[61], decreases the polyP content within the growth plate of
murine vertebral body sections in situ. Finally, we demonstrate that
polyPs reduce hydroxyapatite supersaturation by sequestering free
calcium and also adsorb to hydroxyapatite surfaces in vitro.
Our hypothesis is that apatite is the mineral component of bone
because enzymatic action can control apatite supersaturation at
neutral pH by directly controlling orthophosphate ion activity.
Vertebrate mineralization may then be modulated through the
synthesis and hydrolytic degradation of polyphosphate ions.
Polyphosphates and Apatite
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Electron-dense, calcium- and phosphate-rich granules
are present at bone resorption sites
Using back-scattered electron (BSE) imaging, we observed
electron-dense granules (,5 mm in diameter) within a location
identified as a resorption pit based on its tunneled morphology in
the cortical shell of an undecalcified, 9-month-old guinea pig tibia
(Figure 1A). Energy dispersive X-ray (EDX) analysis of the
granules found in this resorption zone indicated the presence of
calcium, phosphorous, and oxygen atoms. A granule is indicated
within the orange square in Figure 1B. The Pi and calcium signal
intensities of the granules were intermediate to the background
(red square) and the mineralized bone (blue square).
Identification of polyphosphates in a basic multicellular
unit by fluorescence microscopy
Figure 2A shows an example of the spectrum-wide emission
from DAPI-stained vertebral bodies using laser-scanning confocal
microscopy. Fluorescence was collected between 400–700 nm;
after scanning across the same spectral range in 20 nm bins, we
selected various regions of interest and plotted the emission
spectrum (Figure 2A, right). DAPI-polyP complexes were
identified within granules located in regions of bone resorption
by their specific emission wavelength at 520 nm (yellow) [62,63],
whereas regions lacking polyP featured a prominent peak emission
near 460 nm—a characteristic emission wavelength for DAPI-
DNA (blue) (Figure 2A, vertical lines). The image in Figure 2B
(left) was recorded at the 580 nm emission bin, and spatially shows
the regions with a DAPI-polyP complex emission. Regions that
fluoresced at 580 nm included granules set back from a resorption
pit, as well as regions associated with bone resorption (see diagram
in Figure 2B, right). Regions of bone resorption were confirmed by
subsequent staining of the same section for tartrate-resistant acid
phosphatase (TRAP, red), which is a marker for osteoclasts [64],
and counterstaining with haematoxylin (Figure 2C).
Detection of polyphosphates in calcifying cartilage by
fluorescence microscopy
We also detected polyP in 3-month-old murine vertebral body
growth plates that had been decalcified in cold EDTA, dry-
sectioned, stained with DAPI (50 mg/mL), and analyzed by
fluorescence microscopy (Figure 3A). PolyP was detected within
the resting zone (green circle), hypertrophic matrices (blue circle),
proliferating chondrocytes (purple circle), and hypertrophic
chondrocytes (orange circle) by the presence of DAPI-polyP
fluorescence peaks at 520 nm (Figure 3B).
Detection of transient toluidine-blue stained regions in
the growth plate
For this study, we repeated the transient staining of fresh
epiphyseal cartilage reported by Hirschman [51]. Figure 4A shows
the toluidine blue stain one minute after staining, while Figure 4B
shows fading of the stain in the hypertrophic zone matrix of the
same section 10 minutes after staining. The resting zone stain also
transformed from purple to blue. The growth plate regions that
were transiently stained with toluidine blue are similar to the
regions that fluoresced with the DAPI-polyP signature (,520–
580 nm emission maximum, Figure 3).
Reduction of polyphosphate content in the growth plate
by intestinal alkaline phosphatase
If the 520–580 nm DAPI-polyP signal in vertebral growth plates
partially identifies polyPs, then application of intestinal ALP (to
hydrolyze polyPs) should alter the emission profile. The DAPI
emission spectra of ALP-treated and non-ALP-treated control
sections were retrieved from subregions of interest that generally
encompassed the growth plate.
Figure 5 compares representative individual scans and overlays
of emissions at a wavelength indicative of DAPI-DNA (430 nm,
green) and DAPI-polyP (580 nm, red) for the control (2ALP;
Figure 5A,B) and ALP-treated (+ALP; Figure 5C) murine vertebral
body sections. When we displayed the DAPI fluorescence images
collected at 580 nm with respect to 430 nm, we found a unique
spatial distribution for the two wavelength ranges (Figure 5,
overlay column). Thus, the DAPI emission above 580 nm may be
a good index of polyP distribution. The spectral analyses on the
right show representative profiles for the growth plate regions
above the hypertrophic matrix (resting zone, red outline in inset),
within the hypertrophic matrix (green outline), and within the
bone (blue outline). The emission profiles of the hypertrophic
matrix in control sections (Figure 5A,B) showed a shift to longer
wavelengths compared to the other regions, suggesting the
presence of polyPs. An overlay of all control profiles over the
hypertrophic matrix region (Figure 6A) features a long tail of
appreciable DAPI fluorescence extending beyond 580 nm.
Compared to control sections, those sections treated with ALP
(including the one shown in Figure 5C) had limited DAPI emission
above 580 nm in all regions analyzed. The spectral curves for the
hypertrophic matrix region from all ALP-treated sections are
overlaid in Figure 6B. We observed virtually no emission above
580 nm after ALP treatment, suggesting that polyP was not
detectable in the hypertrophic matrix after exposure to active
ALP. Additional analyses suggest that the ALP treatment reduced
the spectral emission to a simpler profile that is more similar to
that of DAPI-DNA. Table 1 summarizes the effect of exposing
sections of murine vertebral growth plate (hypertrophic matrix
region) to ALP (n=3) or buffer (control: n=5, including one
section treated under ALP-inactivating, room temperature condi-
tions) on the DAPI fluorescence emission spectra. ALP application
significantly reduced the intensity of the DAPI emission spectra at
520 nm with respect to the emission at 430 nm. The position of
maximum intensity of the ALP-exposed sections (Figure 6B) was
shifted closer to the emission of DAPI-DNA (460–465 nm). The
FWHM of the emission spectra was decreased by ALP exposure,
indicating a reduction in intensity of one of the convoluted DAPI-
DNA or DAPI-polyP curves. In summary, ALP-treated sections
showed a combination of effects: a reduced DAPI-polyP:DAPI-
DNA ratio (520:430 nm), a peak position shift to lower
wavelengths, and a reduction in the FWHM, consistent with the
reduction in DAPI-polyP emission.
In the control hypertrophic matrix, the shift to a higher and
wider wavelength profile for DAPI fluorescence appears to
represent a composite of DNA and polyP spectral emissions. For
instance, mathematically subtracting an ALP-treated spectral
curve from a control spectral curve yielded an emission curve
with a peak near 540 nm (Figure 6B, dotted line). We performed
two additional experiments to further characterize the spectral
signatures of DAPI bound to DNA instead of to polyPs. First, we
acquired the emission spectra for DAPI-DNA using murine brain
cells as a DAPI-DNA baseline that did not contain appreciable
levels of polyPs. Next, we applied DAPI to synthetic polyPs in
solution, mounted the mixture on a slide, and collected the
emission spectrum (Figure 6C). The DAPI-polyP curve (red) was
rightward shifted compared to DAPI-DNA (green) and also
matched closely with the subtracted curve obtained from the
vertebral growth plates (control minus ALP, Figure 6B dashed
line). Interestingly, adding the DAPI-DNA emission curve to the
Polyphosphates and Apatite
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(pink dashed line, scaled to 0.5). As the DNA:polyP contribution
increased (2:1 black dashes and 4:1 blue dashes), however, the
resulting spectral curve narrowed at the peak and shifted to lower
wavelengths; this effect appears analogous to what we observed in
the ALP experiment (Figure 6B, blue). Once again, the 580 nm
intensity proved to be a good index of polyP contribution (vertical
line in Figure 6C). The more variable emission profiles in the
hypertrophic matrix region between sections may represent a
submixture of polyP and DNA staining and/or difficulty in
maintaining intact polyPs during sample preparation. Regardless,
the simplest interpretation of the bone tissue data is that ALP
Figure 1. Electron-dense granules identified in resorbing bone contain P and Ca. (A) Back scattered electron (BSE) images (high and low
magnification, left and right respectively) and (B) energy dispersive x-ray analysis (EDX) of acetone-dehydrated, SpurrH-embedded, 9-month-old
guinea pig tibial cortical bone, showing intensity (y-axis) vs. emission energy (x-axis). Each spectrum corresponds to analysis of the colored square
region of interest (ROI) defined in (A). Red ROI is background (low Ca, P), blue ROI is mineralized bone (high Ca, P), yellow ROI is an electron-dense
granule (intermediate Ca, P), and green ROI is a polishing grit artifact (Si).
doi:10.1371/journal.pone.0005634.g001
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PLoS ONE | www.plosone.org 5 May 2009 | Volume 4 | Issue 5 | e5634Figure 2. Detection of polyP in a bone resorption site of an EDTA-decalcified, 3-month-old murine vertebra. (A, left) Confocal
fluorescence image (400–700 nm) from a 5–10 micron bone section stained with DAPI and exposed to multiphoton excitation (787 nm). (A, right)
Spectral scans of imaged region (A, left) were acquired in 20 nm bins. Emission intensity was plotted for each of the indicated ROI. Blue ROI: DAPI-
DNA emission. Yellow ROI: DAPI-polyP emission. (B, left) The 580 nm bin emission for the same image captured in (A) spatially resolves DAPI-polyP
distribution. (B, right) Schematic identifies relevant fluorescent regions (A, left) within the resorption zone. (C) The same bone section was
subsequently stained for TRAP and counterstained with haematoxylin (an aqueous process, thought to accelerate hydrolytic degradation of polyP) to
confirm the presence of osteoclasts (red staining) at the resorption site (left and right images correspond to high and low magnification, respectively).
doi:10.1371/journal.pone.0005634.g002
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component that corresponds to polyPs.
Tissue-nonspecific alkaline phosphatase hydrolyzes
polyphosphates, producing orthophosphate ions
Figure 7 shows the result of an in vitro assay of bovine kidney
ALP, a TNAP isoenzyme, with long chain polyPs. Electrophoresis
of the enzymatic digestion products demonstrated that this enzyme
cleaves Pi from synthetic polyPs (average chain length of 25 Pi
units, with some polyP species as short as 3 Pi units). The Pi
concentration increased with time in the +ALP experiment, while
no notable Pi was detected in the 2ALP (control) experiment,
even at the longest time point (30 minutes). Densitometry
measurements of the bands showed an increase in Pi and decrease
in polyP concentrations over time (Supplementary Information,
Figure S1).
Polyphosphates adsorb to hydroxyapatite
The adsorption experiment showed that polyPs adsorb to HAP
(see Supplementary Information Figure S2).
Polyphosphate addition reduces hydroxyapatite
saturation
To calculate the effect of Pi and polyP addition on the HAP
relative saturation, we measured the free calcium, Pi, and pH, and
used those values to calculate the apparent HAP saturation.
Figure 8 shows the effect of increasing Pi concentration (open
circles) or polyP concentration (filled circles) on the apparent
relative saturation of HAP (sHAP) in the unseeded experiments.
sHAP increased with increasing Pi concentration. Raising the
equivalent P concentration by adding polyP lowered sHAP below
the HAP saturation level (sHAP,0) because polyP chelates
calcium.
Discussion
Electron-dense, calcium- and phosphate-rich granules
are present at sites of bone resorption
Calcium- and phosphate-containing granules observed within
resorption pits in undecalcified bone sections and possessing an
intermediate electron density (between that of bone and
unmineralized tissue) may be related to similar calcium- and
phosphate-rich granules previously detected in mineralizing bone
processed under non-aqueous conditions and likewise possessing
an intermediate electron density (between that of unmineralized
collagen and apatite) [48]. Unstained, electron-dense granules in
6-day-old mouse rib have been observed in bone sections prepared
under non-aqueous conditions [48]. The granules observed in this
Figure 3. DAPI identified polyP in vertebral growth plates. Growth plate sections (EDTA-decalcified, 3-month-old murine vertebral body) cut
under non-aqueous conditions and treated with DAPI. (A) Fluorescence emission (400–700 nm) imaged upon multiphoton excitation with emission
wavelength scan analysis (B) by color-defined ROI. Red ROI in sub-chondral bone: emission wavelength profile corresponding to that of DAPI bound
to DNA, not polyP. Other ROI’s: emission wavelength profile with a maximum at ,520 nm, corresponding to that of DAPI bound to polyP.
doi:10.1371/journal.pone.0005634.g003
Figure 4. Transient staining of vertebral growth plates with
toluidine blue. Growth plate sections (EDTA-decalcified, 3-month-old
murine vertebral body) (A) 1 minute and (B) 10 minutes after toluidine
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reported mitochondrial electron-dense clusters in mineralizing
osteoid (ranging from 400–1000 A ˚ in diameter) that are composed
of 50–100 A ˚ electron-dense particles in young rats. These
‘‘mitochondrial granules’’ were detected in osteocytes (bone cells),
osteoblasts, extracellular matrices, and osteoclasts [48].
Mitochondria are known to harbor high concentrations of
bioavailable Pi by storing them as polyP [30,65,66]. A large
number of mitochondria have been observed in osteoclasts
[67,68]. Although the resolution of our technique does not permit
detection of polyP within the mitochondria of bone-resorbing
osteoclasts, the ability of mitochondria to store Pi as bioavailable
polyP suggests that these organelles may be employed by
osteoclasts to scavenge and store the Pi released by apatite
dissolution during bone resorption.
Landis used electron microscopy to measure the size of electron-
dense granules and calculate the Ca:P molar ratio in granules
located within mitochondria (Ca:P=0.8–1.1), osteoid (Ca:P=1.2–
1.3), and mineralized bone (Ca:P=1.4–1.5) [47]. He noted that
the lower Ca:P ratio of the electron-dense granules was similar to
that measured for monetite (CaHPO4; molar Ca:P=1.0) and
calcium polyP (Ca(PO3)2)n; molar Ca:P=0.5). A Ca:P molar ratio
of 0.5 is also expected for a calcium polyP complex (Ca(PO3)2)n.
Producing polyP from Pi is an effective way to decrease the free
(available for chemical reaction) Pi concentration and calcium ion
activity. Osteoclastic production of polyP from Pi retrieved from
dissolved apatite increases total phosphate while avoiding a rise in
calcium phosphate mineral saturation. PolyP formation from the
dissolved apatite within the acidic resorption zone decreases the
saturation of calcium phosphate minerals such as brushite
(CaHPO4?2H2O) that would otherwise be expected to remain
stable in the acidic resorption zone. Granules containing polyP,
which could also contain sequestered calcium, are capable of co-
localizing high concentrations of the major ionic components of
apatite without precipitating apatite crystals within volumes of
neutral pH either inside or outside the osteoclast.
Figure 5. Resolving polyP distribution by spectral isolation of DAPI 580 nm emission and attenuation by alkaline phosphatase
(ALP) treatment. (A) Control growth plate section; (B) a different control growth plate section (higher magnification); (C) ALP-treated (+ALP) growth
plate section. First column, green: 430 nm emission (DAPI-DNA) Second column, red: 580 nm emission (DAPI-polyP). The third column is an overlay of
the 430 and 580 nm images to show the spatial distribution of polyP that occurred primarily in the hypertrophic zone of control sections but was
absent in ALP-treated sections. The spectral analyses in the last column show profiles for the various ROI outlined in the smaller inset image. Growth
plate regions analyzed included the region above the hypertrophic matrix (red ROI), in the hypertrophic matrix (green ROI), and in the bone (blue
ROI). The emission profile of each control (2ALP) hypertrophic matrix (green ROI) shows a shift to a higher wavelength emission compared to the
other 2ALP regions, suggesting the presence of polyP. All regions analyzed in +ALP sections showed an emission profile similar to that of DAPI-DNA,
suggesting polyP was hydrolyzed from the hypertrophic matrix after exposure to active ALP. All scale bars represent 150 mm.
doi:10.1371/journal.pone.0005634.g005
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content of electron-dense, non-crystalline granules identified in
mitochondria exceeded the solubility product of calcium phos-
phate [37] without forming crystalline apatite mineral. One
possible explanation for these amorphous granules being super-
saturated with respect to apatite is that the measured Pi was
originally present as polyP. Therefore, if the phosphate is present
as polyP, the formation of crystalline apatite may not be
thermodynamically favored. We hypothesize that polyPs produced
by the mitochondria in osteoclasts permit the storage of high
concentrations of bioavailable Pi without forming apatite, and
allow for the transport of high concentrations of phosphate to
locations such as osteoid (Figure 9A).
Polyphosphates and pyrophosphates are known to inhibit the
growth of apatite mineral [15–17]. The destruction of pyrophos-
phate by TNAP in the presence of Type I collagen has been shown
to induce mineralization [69]. While polyP may likewise act as an
apatite growth inhibitor, polyP-calcium complexes can also form
concentrated amorphous granules with a composition of calcium
and phosphate (0.5 M) that is greater than the solubility product of
apatite [37] or calcium pyrophosphate [41,42]. This ability of
polyP to amass high concentrations of calcium and phosphate
permits the accumulation of the major components of apatite for
its controlled mineralization by ALP in neutral pH environments.
Identification of polyphosphates in calcifying cartilage by
fluorescence microscopy
Shapiro and Boyde [70] proposed that the rate-limiting step for
cartilage calcification was the transport of Pi from the cartilage
cells to the calcifying cartilage matrix. Electron-dense ‘‘spherules’’
ranging in size from 200–800 A ˚ were also identified within
mitochondria of the chondrocytes (cartilage cells) in the prolifer-
ative and hypertrophic zones of fresh, stained, tibial epiphyseal
Figure 6. DAPI emission in the hypertrophic zone is a
convolution of DAPI-DNA and DAPI-polyP emissions. (A) 2ALP
(control) emission spectra from control sections show a large
fluorescence contribution above 580 nm. (B) Sharper and lower
wavelength emission profile in sections treated with ALP to hydrolyze
polyP. The spectral shift due to ALP treatment (control – ALP) is
indicated by the red dashed line. (C) Emission profile of polyP-poor
murine brain cells (green lines) contrasts with that of rightward-shifted
emission from synthetic polyP (red lines). Summing DAPI-DNA-rich and
polyP curves (1:1 ratio, peak re-scaled to 0.5), yields a complex, wide
emission profile (dashed pink line); as the DNA:polyP contribution is
increased (2:1 and 4:1), the composite emission profile shifts to the left
and the peak width narrows.
doi:10.1371/journal.pone.0005634.g006
Table 1. Effect of ALP exposure to DAPI emission spectra of









2ALP (control) 2.1460.84 490614 120610
+ALP 0.6460.21 469658 8 64
p (t-test) 0.02 0.05 0.01
doi:10.1371/journal.pone.0005634.t001
Figure 7. TNAP cleaves Pi from polyP. Separation of synthetic
polyP exposed to TNAP by polyacrylamide gel electrophoresis. TNAP
exposure times were 0.5, 1, 2.5, 5, 10, 15, 20, and 30 minutes. Right lane
is TNAP- (control) for 30 minutes (C) and the far left lane is a
pyrophosphate (P2O7)
42/Pi ladder. Synthetic polyP contains a range of
polyP species, from (PO3
2)3 (3 condensed Pi units) to polyP chains
longer than 28 Pi units.
doi:10.1371/journal.pone.0005634.g007
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spherules were spotted in the extracellular regions of the
proliferative and hypertrophic zones [43]. These granules were
not observed when the tissue was prepared with aqueous methods,
suggesting they may have been composed of polyP. Labile calcium
and phosphate-containing spherules were also detected within the
cytoplasm of chondrocytes and adjacent to hypertrophied
chodrocytes in the matrix of fresh, calcifying cartilage [71]. With
the detection of polyP in these specific regions of the growth plate,
we hypothesize that polyP granules produced by the proliferating
chondrocytes are secreted into the calcium-rich lower hypertro-
phic zone matrix (Figure 9B). Accelerated hydrolytic degradation
of polyP with ALP in polyP-calcium complexes would provide a
source of Pi and calcium for apatite precipitation (Figure 9C).
Landis and Glimcher previously quantified the calcium and
phosphate ratio for different calcium phosphate minerals, bone
mineral, and electron-dense granules detected in calcifying
cartilage [43]. They demonstrated that these dense granules
detected in the proliferating and hypertrophic chondrocytes of the
growth plate exhibited no crystalline structure and contained
calcium and phosphorus in molar ratios ranging from 0.8060.05
to 1.0760.24. Within the extracellular matrix, the Ca:P molar
ratio increased from 0.8860.12 in the mid proliferating zone to
1.5160.09 in the zone of calcifying cartilage. The Ca:P molar
ratio in the unmineralized areas of the growth plate fell between
the values measured for linear polyphosphate ((Ca(PO3)2)n; 0.50)
and brushite (CaHPO4; 1.03). The Ca:P ratio in calcifying
cartilage is closer to that of hydroxyapatite (1.62). Another study of
the epiphyseal growth plate showed that Pi-containing matrix
granules were distinct from Ca-rich sites in the unmineralized
upper regions, and calculated Ca:P ratios of 1.0 near the zone of
provisional calcification [72].
The measurement of Ca:P molar ratios of less than 1 in
electron-dense, amorphous granules in the proliferating extracel-
lular zone and in the proliferating and hypertrophic chondrocytes
can be explained by the presence of a polyP component, because
polyP can form calcium complexes with Ca:P ratios as low as 0.5.
Toluidine blue staining of the growth plate
We successfully reproduced the transient toluidine blue staining
reported by Hirschman and McCabe to compare it with DAPI
staining of polyP in the growth plate. Toluidine blue undergoes a
metachromatic shift when complexed with polyP; the size of the
shift depends upon the concentration of polyanionic charges
[73,74]. Therefore, the different metachromatic shifts of toluidine
blue in the fresh rat epiphyseal cartilage may have been due to
polyP ions of different chain length and/or concentrations. Fading
of the toluidine blue stain in the matrices of the resting and
hypertrophic zones may have been caused by a loss of the polyP
substrate. This loss of substrate would have resulted from polyP
hydrolytic degradation when the thin tissue sections were exposed
to water, because polyPs are thermodynamically favored to
undergo hydrolytic degradation [19].
Although toluidine blue stain is not specific for polyP, previous
research found that the areas of the fresh rat epiphyseal cartilage
that stained with toluidine blue also stained with neutral red and
methylene blue [50], both of which also stain polyP [23]. These
observations further support the finding of polyP in these zones
with DAPI and fluorescence microscopy.
Reduction of polyphosphate content in growth plate
sections with intestinal alkaline phosphatase
The application of intestinal ALP to an EDTA-demineralized, dry-
cut section of murine growth plate reduced the intensity of the DAPI-
polyP emission spectra. We conclude that the intestinal ALP
increased the hydrolytic degradation rate of polyP present in the
section. The reduction in polyP content resulted in a decreased
intensity of the DAPI-polyP emission spectrum near 520 nm,
sharpening the total emission spectrum towards a DAPI-DNA
emission curve. Given the low resolution of this technique, we used
the emission from a region of interest spanning the zones of the
growth plate to measure the effect of ALP addition on the emission
curve.
We determined that the critical wavelength bin between 580–
700 nm is a reliable and specific measure of DAPI-polyP
distribution. DAPI fluorescence from both the ALP-treated sections
and also the polyP-poor signal measured in murine brain cells
showed a negligible contribution above 580 nm. We were able to
image the 580 nm DAPI-polyP emission and found the strongest
fluorescence within the hypertrophic matrix region of the vertebral
growth plate (Figure 5). It should be possible to use this approach to
further study the process of vertebrate skeletal mineralization.
Tissue-nonspecific alkaline phosphatase hydrolyzes
polyphosphates, producing orthophosphate ions
Figure 7 indicates that Pi is a hydrolytic degradation product of
polyP by TNAP. The action of bovine TNAP on inorganic polyP,
cleaving Pi from the ends of polyP chains, classifies this enzyme as
an exophosphatase [23].The production of only Pi from Ca-polyP
granules by TNAP would increase the Pi concentration and
calcium ion activity through the release of calcium ions from their
chelation with polyP. In addition, the hydrolytic degradation of
polyP present in calcium-rich environments, such as the growth
plate, may also increase the Pi concentration, thereby raising
apatite saturation and providing sufficient thermodynamic driving
Figure 8. The effect of adding P to a HAP-saturated, unseeded
solution depends on the speciation of P. Increasing the equivalent
P concentration by adding Pi to a solution saturated with HAP and
without any HAP crystals in solution (unseeded) increases the relative
HAP saturation (sHAP.0, open circles). Addition of P as polyP
(unseeded) decreases the apparent saturation of HAP to an undersat-
urated state (sHAP,0, closed circles). PolyP addition sequesters calcium,
reducing calcium activity in solution without changing the free Pi
concentration appreciably. Although supersaturated with respect to
apatite when calculated with the total calcium and phosphate
concentrations, HAP solids would be expected to dissolve when
calcium sequestered by polyphosphates effectively generates a system
undersaturated with respect to HAP.
doi:10.1371/journal.pone.0005634.g008
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localization of polyP and ALP in the mineralization sites of
remodeling bone and calcifying cartilage would suggest that
apatite crystal nucleation may be a consequence of ALP
controlling the hydrolytic degradation of polyP into Pi ions in
the presence of free calcium.
Figure 9. Schematics of hypothesized roles of polyP in the mechanisms of phosphate transport in remodeling bone and calcifying
cartilage, and apatite crystal precipitation. (A) Hypothesized mechanism of phosphate metabolism and transport as polyP in
osteoclastic bone resorption and bone mineralization. Apatite mineral dissolution in the osteoclast resorption zone increases the
concentrations of free Pi and Ca
2+. The mitochondria may scavenge the Pi and condense them into polyP that may also sequester Ca
2+. Amorphous
granules containing total concentrations of Ca
2+ and Pi higher than the saturation of apatite are formed and may be transported out of the
osteoclast. The granules may be transported to or produced within the osteoblasts that build new bone. The osteoblasts may embed the granules in
osteoid (new, unmineralized bone). The reaction of these granules with alkaline phosphatase (ALP, present at the membrane of osteoblasts) cleaves
Pi from polyP and would increase the free Pi concentration and release any sequestered Ca
2+. The increase in free Ca
2+and Pi could exceed the
saturation for apatite and result in apatite mineral formation. (B) Hypothesized role of polyP in growth plate mineralization. PolyPs are
condensed within the proliferative zone chondrocytes, possibly by mitochondria. PolyP-containing, amorphous, electron-dense granules are
transported to the chondrocytes in the hypertrophic zone matrix. PolyP ions may chelate with Ca
2+, resulting in high total concentrations of Ca
2+ and
Pi locally but no apatite formation. ALP cleaves Pi from the polyPs, increasing the free Pi concentration and releasing any sequestered Ca
2+. The
increase in free Pi and Ca
2+concentrations may exceed the saturation of apatite, resulting in apatite mineral formation. (C) Hypothesized process
of precipitating apatite crystals from calcium polyP complexes with ALP. Calcium polyP complexes release sequestered Ca
2+ and Pi when
ALP cleaves Pi from the end of polyP chains. The increased free concentrations of Ca
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saturation
Increasing the free Pi concentration in a HAP-saturated,
unseeded system increased the sHAP. This is an expected result
because free Pi concentration is proportional to sHAP. The polyP
adsorption experiment showed decreasing apparent sHAP in an
HAP-saturated system that contained no HAP crystals (unseeded).
The reduction in sHAP observed with increasing polyP concen-
tration may be attributed to the formation of calcium-polyP
complexes in solution. The ability of polyP to sequester calcium
may reduce the activity (free concentration) of calcium ions in the
initially HAP-saturated solution. The measurement of very low
free calcium with increasing polyP addition (Figure S2) suggests
that the additional polyP ions formed stronger complexes with
calcium than with the colorimetric agent used to measure calcium
concentration. The resulting reduction in calcium ion activity
(aCa2+) would decrease the HAP ionic product (IAPHAPR0), and
hence reduce sHAP to values,0. In this induced undersaturated
state, the HAP seed is predicted to dissolve.
During the seeded polyP adsorption experiment, HAP seed
crystals dissolved as total calcium ion and hydroxyl concentrations
increased with the increasing addition of polyP (Figure S2). Adding
polyP to the HAP-saturated solution reduced the free calcium
concentration, causing an undersaturation of the solution with
respect to HAP and thus favouring the dissolution of the HAP
seed.
Adding only polyP to a solution saturated with HAP is not
expected to change the free Pi concentration appreciably. In an
aqueous solution, however, thermodynamics predicts the sponta-
neous, hydrolytic degradation of polyP into Pi ions [19], although
the kinetics are slow. Some polyP hydrolytic degradation in our
experimental conditions may explain the increase in Pi concen-
tration in the unseeded experiment (Figure S2), an observation
that also would be explained by dissolution of HAP seed crystals.
These results suggest that a system containing polyP and
sequestered calcium could exhibit low Pi and free calcium
concentrations, indicating an undersaturated system with respect
to HAP. PolyP hydrolytic degradation of the same system,
however, would produce free Pi and calcium, revealing a system
oversaturated with respect to HAP. This dichotomy may explain
why previous researchers have observed amorphous, electron-
dense granules with total calcium and phosphate concentrations
exceeding the saturation of apatite, but never detected the
presence of apatite crystals.
Hypothesis
Polyphosphate ions identified at bone-resorbing osteoclastic
sites, in the proliferating and hypertrophic zone chondrocytes, in
the hypertrophic zone matrix, and postulated to be present in
unmineralized osteoid may provide a phosphate reserve and
mechanism for controlling biological apatite mineral deposition.
We propose that polyphosphates are formed or incorporated
within the skeleton where high local concentrations of orthophos-
phate exist and where mineralization is not desired. High
concentrations of calcium and phosphate can be transported from
bone resorption zones as bioavailable calcium-polyphosphate
complexes while remaining below the saturation of apatite. If
transported as polyphosphate ions, phosphate ions may be ferried
to regions of high calcium concentration in pre-calcifying cartilage
without risking apatite formation. When mineralization is desired,
alkaline phosphatase would accelerate the hydrolytic degradation
of polyphosphates, releasing orthophosphates and any sequestered
calcium. At a neutral pH, this polyphosphate hydrolytic
degradation reaction would increase the orthophosphate and free
calcium concentrations, raising apatite saturation and supplying
the driving force for biological apatite formation.
This flexible, enzymatic control of mineralization explains why
the vertebrate skeleton is composed of apatite. Carbonates do not
condense and silicates condense but are not hydrolytically
degraded in biological systems. Phosphates are condensed by
polyphosphate kinases and orthophosphates are produced by the
hydrolysis of polyphosphates with alkaline phosphatase. The
enzymatic control of orthophosphate activity provides a simple
and efficient method for controlling apatite mineral formation in
vertebrates. We therefore propose that polyphosphates are an
efficient modulator of apatite biomineralization in vivo. Apatite
mineralization and demineralization in growing, continually
remodeled bone and cartilage-containing vertebrate skeletons
may be regulated by the enzymatic control of polyphosphate
synthesis and degradation.
Methods
Back scattering electron (BSE) imaging and energy
dispersive X-ray spectroscopy (EDX)
PolyP solubility is lower in acetone than in aqueous solutions
[75]. To reduce the polyP dissolution during sample preparation,
we used acetone-dehydrated, undecalcified, 9-month-old excised
guinea pig tibiae cut coronally and embedded them in SpurrH
resin (Electron Microscopy Sciences, Hatfield, PA). All sections
were dry-polished with 4000-grit paper. We generated BSE images
in an ESEM (XL30, FEI Company, Hillsboro, OR, 20 kV, 60 mA)
and collected qualitative EDX spectra (Phoenix EDX detector,
EDAX, Mahwah, NJ).
Identification of polyP in skeletal tissue by fluorescence
microscopy
We used fluorescence microscopy to identify polyPs via the
specific fluorescence of the DAPI-polyP complex, which differs
markedly from the fluorescence of the DAPI-DNA complex. DAPI
has been used to identify polyPs in phytology, microbiology, and
molecular biology because the emission wavelength for the DAPI-
polyP complex is shifted towards 520 nm, in contrast to the 460–
465 nm emission fluorescence of the DAPI-DNA complex
[23,26,62,76].
We demineralized 3-month-old murine vertebral bodies (0.3 M
EDTA, pH 7.4, 4uC, 10 days), embedded them in paraffin wax,
dry sectioned them to 5–10 microns (Reichurt-Jung BioCut 2030,
Leica Microsystems Canada Inc., Richmond Hill, ON) and
mounted them on slides. For removing bone mineral, we preferred
the cold EDTA processing method over acid because hot and/or
acidic conditions are known to accelerate the kinetics of polyP
hydrolytic degradation [77]. Some of the cold sections were
stained with DiI (2% in ethanol, 30 min, D-282, Invitrogen
Canada Inc., Burlington, ON) to identify the plasma membranes.
DiI was used to navigate sections excited by a 488 nm laser.
Without dewaxing, all sections were exposed to DAPI (50 mg/mL
in 0.2 M TRIS, pH 9, 5 min, Pierce Biotechnology, Inc.,
Rockford, IL) for 2 minutes, then rinsed with TRIS (0.2 M,
pH 9) solution.
The labeled sections were excited with a multiphoton laser
(Milennia XS – Tsunami, SpectraPhysics, CA) at ,780 nm, in
accordance with the suggested DAPI excitation wavelengths by
Neu et al. [78]). The multiphoton laser was directly coupled to a
Leica SP2 confocal scanning microscope system. Wavelength
scans (xyl) were acquired in 20 nm bins (400–700 nm) that
allowed spectral analysis of the emission spectra. The DAPI-DNA
complex emission peak was detected and identified based on its
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based on its 520–580 nm emission (Figure 10, solid lines). We
assumed that emissions at 580 nm represented DAPI-polyP
emissions minimally convoluted with DAPI-DNA ones
(Figure 10, red dashed line); we therefore used the 580 nm
emissions to represent DAPI-polyP emission regions (for example,
in Figures 2, 5). The DAPI-DNA emissions for Figure 10A were
collected from a murine brain section, while Figure 10B depicts
the emission spectra from a solution of 10 mg/mL sodium
polyphosphate (Type 28, Sigma-Aldrich) and 10 mg/mL DAPI
in TRIS (0.2 M, pH 9). Spectral scans were analyzed with Leica
LCS or Leica LiteH software. Mathematical subtraction or
addition of spectral emission curves (Figure 6C, dashed lines)
was re-normalized so that the peak intensity equaled 0.5 before
plotting.
Tartrate-resistant acid phosphatase staining
We used a kit (Sigma-Aldrich # 181-A) to stain for tartrate-
resistant acid phosphatase (TRAP) as a marker for osteoclasts [64].
Each decalcified, dewaxed section was incubated for 2 hours with
a mixture of naphthol AS biphosphoric acid (12.5 mg/mL),
tartrate solution (0.67 M final conc., pH=5), acetate solution
(2.5 M final conc., pH=5), and fast red TR salt (0.1 g/10 mL).
The section was then counterstained with haematoxylin.
Toluidine blue staining
Demineralized (0.3 M EDTA, pH 7.4, 4uC, 10 days), 3-month-
old murine vertebral bodies were embedded in paraffin wax, dry
sectioned to 5–10 microns (Reichurt-Jung BioCut 2030) and
mounted on slides. We stained sections with toluidine blue (0.01%
(Sigma-Aldrich), 0.01 M acetate, pH 4, filtered) for up to
10 minutes [50] and imaged them using a Retiga 1300 Camera
with QImaging (image capture software suite 2.0), a Zeiss
microscope with a Dell Optiplex GX240, and a resolution set at
10246768.
Reduction of polyphosphate content in the growth plate
with alkaline phosphatase
We prepared sections of growth plates from wild type murine
vertebral bodies/tibial plateaus as described for polyphosphate
detection by fluorescence microscopy. Immediately before staining
and imaging, we cut 5–10 micron sections and exposed them to
either an ALP-free buffer solution serving as control (10 mM
TRIS, pH 8.2, 50 mM KCl, 1 mM MgCl2, 0.1 mM ZnCl2,3 7 uC;
Sigma-Aldrich, 0.2 M, pH 9) or to an intestinal ALP solution
(10 U/mL ALP, bovine calf intestine, P7923-2KU, Sigma-
Aldrich, dispersed in buffer) for 5 minutes. We applied ALP to
accelerate the hydrolytic degradation of polyP within the growth
plate section. All sections were subsequently exposed to DAPI
(50 mg/mL) for 2 minutes. After a rinse with TRIS solution, the
sections underwent a spectral scan as described for polyP detection
by fluorescence microscopy.
In order to compare the emission spectra, we used data
collected with the Leica LCS software to determine the position of
maximum intensity, the spectrum intensities at 430 and 520 nm,
and the full width at the half-maximum intensity (FWHM) of the
intensity-wavelength curves. The emission spectra for the DAPI-
DNA and DAPI-polyP curves are convoluted; there is minimal
overlap in the two emission spectra at 430 and .500 nm
(Figure 10). In order to quantify the emission data, the intensity
at 430 nm was used as an index of the DAPI-DNA emission
(Figure 10, blue dashed line), while the intensity at 520 nm
represented the DAPI-polyP component (Figure 10, yellow dashed
line). The ratio of emission intensities at 520 nm and 430 nm is
proposed to represent the relative intensity of DAPI-polyP in the
convoluted emission spectra; when calculating this 520:430 nm
ratio, the intensity values were first subtracted from the individual
background intensity. We have assumed that ALP selectively
decreases the DAPI-polyP emission spectrum by accelerating the
hydrolytic degradation of the polyP while leaving the DNA
unaffected.
We propose that the wavelength position of maximum intensity
and the full width at half max (FWHM) also provide information
about the contribution of the DAPI-polyP emission spectrum to
the total DAPI-DNA/DAPI-polyP spectrum. A reduction of the
DAPI-polyP component of the convoluted spectra is assumed to
result in a shift of the position of maximum intensity to shorter
wavelengths as well as a reduction in the FWHM of the total
emission curve. In some of the images (Figures 2, 5), we show that
the DAPI fluorescence at 580 nm indicates the polyP signal; the
use of 580 nm as an index is based on the fact that we found
Figure 10. Emission spectra of DAPI-DNA and DAPI-polyP. (A) Emission spectra of DAPI-DNA obtained from murine brain section. Note
position of maximum intensity at 460 nm, intensity at 430 nm, and intensity at 520 nm. The intensity at 430 nm is used as a proxy for the
contribution of the DAPI-DNA curve to the convoluted DAPI-DNA-polyP spectra. (B) Emission spectrum of DAPI-polyP obtained from synthetic polyP.
Note position of maximum intensity near 520 nm and minimal intensity at 430 nm. The intensity at 520 nm is used as a proxy for the contribution of
the polyP to the convoluted DAPI-DNA-polyP spectra in bone sections. Fluorescence above 580 nm is exclusively due to DAPI-polyP emission and
was used for imaging purposes in Figures 2 and 5.
doi:10.1371/journal.pone.0005634.g010
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580 nm while more than a third of the DAPI-polyP profile
remained at wavelengths above 580 nm (Figure 6).
Tissue-nonspecific alkaline phosphatase enzymatic assay
We mixed bovine kidney alkaline phosphatase (a tissue-
nonspecific alkaline phosphatase [54]) (Calzyme Laboratories,
Inc. San Luis Obispo, CA) at a final concentration of 7 units/mL
in 0.2 M TRIS (Sigma-Aldrich, pH 9) with sodium polyP (Type
28, Sigma-Aldrich in 0.2 M TRIS, pH 9, final concentration
30 mM equivalent Pi) and incubated the mixture at 37uC. TNAP-
free, polyP solutions served as the control. Aliquots taken at each
time point were mixed with an equal volume of 0uC, 1 M NaOH
solution. We used polyacrylamide gel electrophoresis (PAGE) to
separate the phosphate species in 25 mL samples of a mix
containing a 1:1.5 ratio of denatured aliquots (initial polyP
solution, TNAP time points, or the TNAP-free final time point
serving as a control) to sample buffer (90 mM TRIS, 90 mM
borate, 2.7 mM EDTA, 0.05% bromophenol blue, pH 9, 20%
sucrose).
Vertical slab gels (200620060.5 mm) were cast with 16%
polyacrylamide (19:1 bisacrylamide:acrylamide ratio, 7 M urea
and 16TBE (90 mM Tris, 90 mM borate and 2.7 mM EDTA,
pH 8.3 [25,79])). The standard lane contained Pi (20 nmoles) and
pyrophosphate (P2O7
42, 20 nmoles) ladders. The polyphosphate/
phosphate products were separated at approximately 15 V(cm)
21
with internal water cooling for 1.5–2 hours, then visualized with
methyl green after in situ hydrolytic degradation [80].
Adsorption of polyphosphate to hydroxyapatite
In order to determine whether longer chain polyP molecules
could adsorb to HAP crystals in solution, we adapted the
sequential method from Michelmore et al. [81] with a background
electrolyte of 0.15 M NaCl pre-saturated with synthetic HAP.
Synthetic HAP (Sigma-Aldrich, Milwaukee, WI) was used as a
proxy for the apatite mineral in bone.
In this method, we sequentially added phosphate, as either Pi
(0.01 M equivalent phosphate (Na2HPO4)) or polyP (Na(PO3)n,
Type 28 (average polyP chain length=25 Pi, Sigma-Aldrich,
both dissolved in 0.15 M NaCl pre-saturated with HAP)), into
HAP-presaturated solutions that were either unseeded (contained
no HAP mineral seeds) or seeded (contained 2 g/L HAP aged
mineral seed in suspension). The amount of Pi or polyP added
was normalized to moles of equivalent P by calculating the total
moles of Pi added as Pi or polyP. We collected an aliquot (0.5%
of the initial volume) from the test solution before each
incremental delivery (0.5% of the initial test volume) of Pi or
sodium polyP.
Aliquots were centrifuged (10,000 rpm, 5 min) and the
supernatant analyzed for free calcium with ortho-cresolphthalein
[82] and free Pi with vanadomolybdate [83] by colourimetry. We
mixed equivalent volumes of the supernatant samples with 0.1 M
HCl in microtubes and heated them to 100uC overnight to
completely hydrolytically degrade the polyP before measuring the
total (free+sequestered) calcium and total (ortho+polyphosphate)
Pi concentrations [84]. Acidified solutions were neutralized with
0.1 M NaOH before colourimetric analysis of total calcium
concentrations to maintain a basic pH for the assay.
We concluded that an adsorption of Pi or polyP to the HAP
seed occurred if the total Pi concentration was reduced in the
supernatant solutions that contained HAP seed compared to those
that did not contain it for equivalent phosphate species
additions.
Measurement of HAP-relative saturation
The relative supersaturation with respect to HAP (sHAP)i sa
function of the thermodynamic solubility product (Ksp) and the











where S is defined as saturation [85], a is the ion activity, and s is
defined as relative saturation. s is an indicator of the
thermodynamic force driving towards dissolution or growth of a
specific phase in solution. A relative saturation of zero (s=0)
represents an ideal system in which the solution is at thermody-
namic equilibrium with the salt. Supersaturated systems (s.0)
favor nucleation and growth, while undersaturated systems (s,0)
progress towards mineral dissolution.
Ionic activities (a), representing the chemical potential of an ion
in solution, are a function of the ion molal (mol/kg solvent)
concentration and the activity coefficient (c), which in turn is a
function of the ionic strength and composition of the solution. The
ionic activity is an indicator of the ‘‘free’’ concentration of an ion
in a given solution. We calculated the relative saturation of HAP
using the free calcium, Pi, and pH data [85,86] for the HAP-
seeded solutions studied in the adsorption experiment.
Supporting Information
Figure S1 Densitometry of Figure 7 – TNAP cleaves Pi from
polyP. Separation of synthetic polyP exposed to TNAP by
polyacrylamide gel electrophoresis (PAGE). TNAP exposure times
were 0.5, 1, 2.5, 5, 10, 15, 20, and 30 minutes. Plot of the signal
intensity from polyP (filled circles), tripolyphosphate ((P3O10)
52,
open circles), and orthophosphate (Pi, filled triangles) with
increasing exposure to TNAP. Synthetic polyP contains a range
of polyP species, from tripolyphosphate (3 condensed Pi units) to
polyP chains longer than 28 Pi units. With increasing exposure to
TNAP, the PAGE shows a trend of increasing Pi and decreasing
polyP concentration.
Found at: doi:10.1371/journal.pone.0005634.s001 (0.36 MB TIF)
Figure S2 Orthophosphate (Pi) and polyphosphate (polyP)
adsorption data to synthetic hydroxyapatite (HAP) in 0.15 M
NaCl saturated with respect to HAP. After complete hydrolytic
degradation of the supernatant in hot, acidic conditions, the
measured free Pi concentration is assumed to represent the total Pi
concentration. The free calcium concentration after hydrolytic
degradation is also assumed to represent the total calcium
concentration (unseeded: without HAP crystals; seeded: with
HAP crystals). The data will be discussed with respect to the Pi
adsorption experiment, followed by the polyP adsorption exper-
iment. Pi adsorption data: Free, unseeded (A, open circles) and
seeded (A, open triangles) Pi concentrations with increasing Pi
addition were similar, indicating no measurable adsorption of Pi to
HAP. The same increase in total Pi with Pi addition was also
observed for the unseeded (B, open circles) and HAP-seeded (B,
open triangles) adsorption experiments. The free calcium
concentrations (C, open circles), total calcium concentrations (D,
open circles), and pH (E, filled circles) in the unseeded Pi
adsorption experiment remained unchanged. For the HAP-seeded
experiment, the free calcium concentration decreased slightly with
increasing Pi addition (C, open triangles), as did the pH, which is
also affected by the buffering capacity of Pi (F, closed circles). This
result suggests some HAP seed growth as a consequence of Pi
Polyphosphates and Apatite
PLoS ONE | www.plosone.org 14 May 2009 | Volume 4 | Issue 5 | e5634addition to the HAP-saturated system. Increasing the Pi
concentration would be expected to increase the HAP saturation,
favouring HAP crystal growth. PolyP adsorption data: The free Pi
concentration in the polyP adsorption experiment increased
slightly with time for the unseeded (A, filled circles) and HAP-
seeded (B, filled triangles) experiments. The addition of polyPs to a
solution saturated with HAP is not expected to change the free Pi
concentration appreciably. In an aqueous solution, however,
thermodynamics predicts the spontaneous hydrolytic degradation
of polyP into Pi ions. Some polyP hydrolytic degradation in our
experimental conditions may explain the increase in Pi concen-
tration in the polyP adsorption experiment (A, filled symbols) and
decrease in pH (E, open circles). Hydrolytic degradation of polyP
in the supernatant showed a lower total Pi concentration for the
HAP-seeded experiment (B, filled triangles) than the unseeded (B,
filled circle) experiment, indicating adsorption of polyP to HAP
seed. Free calcium concentrations in the supernatant of the polyP
addition experiment decreased to zero for the unseeded system (C,
filled circles) and to lower concentrations than those to which Pi
was added for the HAP-seeded system (C, filled triangles). We
assumed that the sequestration of calcium by polyP was stronger
than the indicating calcium-orthocresolphthalein complex; there-
fore no free calcium was detected by colourimetry. For the
unseeded system, the total calcium concentration (D, filled circles)
remained unchanged with increasing polyP. Interestingly, the total
calcium concentration (D, filled triangles) and pH (F, open circles)
both increased with increasing polyP addition in the HAP-seeded
system, suggesting dissolution of the HAP seed during the
adsorption experiment.
Found at: doi:10.1371/journal.pone.0005634.s002 (0.88 MB TIF)
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